Clinical Trial Update: Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update covers a Phase 1/2 study evaluating Human Immune Globulin for AL amyloidosis-related heart dysfunction. Results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Al Amyloidosis
• Multiple Myeloma
• Plasma Cell Neoplasm

Drugs mentioned

• Human Immune Globulin (intravenous immunoglobulin (IVIG))

Snippet

Sponsor: University of Tennessee | Conditions: Multiple Myeloma, Plasma Cell Neoplasm | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2013-09-19